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a b s t r a c t
IFN plays an important part in immunity to tuberculosis (TB), but although it is necessary, it is not on
its own sufﬁcient for protection against TB. To identify other cytokines that play a role in the protection
against TB induced by BCG vaccination, immune responses were compared between vaccinated and
unvaccinated infants from the UKwhere BCG is known to provide protection. Twenty-one cytokines and
chemokines were tested in supernatants from diluted whole blood cultures that had been stimulated
for 6 days with Mycobacterium tuberculosis PPD. For 15 out of 21 of the cytokines tested responses were
much higher in BCG vaccinated infants than in unvaccinated infants. These included: pro-inﬂammatory
cytokines; IFN (median 1705pg/ml vs. 1.6 pg/ml in vaccinated and unvaccinated infants, respectively),ytokines TNF (median 226pg/ml vs. 18pg/ml), as well as IL-2, IL-1 and IL-6; TH2 cytokines: IL-4, IL-5 and IL-13
(median 104pg/ml vs. 1.6 pg/ml); the regulatory cytokine IL-10 (median response 96pg/ml vs. 8 pg/ml);
the TH17 cytokine IL-17, chemokines (IP-10, MIP-1 and IL-8) and growth factors (GM-CSF and G-CSF).
The greatest increase in cytokineproduction inBCGvaccinees compared tounvaccinated infantswas seen
with IFN. While responses formany cytokineswere correlatedwith the IFN response, others including
IL-17 and IL-10 were not. The pattern of cytokine induction following BCG vaccination is complex and
o cymeasurement of one of tw
. Introduction
Bacille Calmette-Guerin (BCG), the vaccine for protection
gainst tuberculosis (TB), is currently given to most of the world’s
nfants as part of the WHO’s Expanded Program on Immunisa-
ion (EPI) [1]. Clinical trials of BCG show variable efﬁcacy (0–80%)
gainst pulmonary tuberculosis in adults [2], but high efﬁcacy in
nfants against the severe forms of childhood tuberculosis [3].
Several new TB vaccines are being tested or are soon to be
ested in clinical trials [4]. Some of these would be given as
ooster vaccines following BCG vaccination, and others are geneti-
ally modiﬁed BCG vaccines. Biomarkers of protection are urgently
equired tohelpassess thesenewTBvaccines, aswithout themclin-
cal trials will be lengthy and require very large numbers of study
ubjects [5]. Studying immune responses to BCG vaccination in the
K, where BCG vaccination has been shown to provide 75% protec-
ion, gives us an opportunity to identify biomarkers of protection
ollowing successful vaccination against TB.
BCG vaccinated infants in the UK have been found to make an
FN response to M.tb PPD in stimulated 6-day whole blood cul-
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tures, while unvaccinated infants do not make a detectable IFN
response [6]. Though the TH1 cytokine IFN plays an important
part in immunity to TB [7–9], it is not sufﬁcient on its own to pro-
tect against TB, and other cytokines, such as TNF, also play a role
in immunity to TB [5].
This study was designed to identify which cytokines other than
IFN are induced following BCG vaccination in UK infants, and the
associations between the various cytokines produced. The Multi-
plex assay has the advantage of being more sensitive than ELISA,
and to be able to measure multiple cytokines in a small blood sam-
ple, and so is appropriate for studies of infants. The study aims
to characterise cytokine patterns induced following vaccination
against tuberculosis, which could, in turn, suggest promising can-
didates for biomarkers of protection for clinical trials of new TB
vaccines.
2. Methods
2.1. Recruitment and study design
Open access under CC BY license. Twenty-eight Caucasian infants who were born in the UK, and
who were part of our BCG vaccination study in which we had
measured IFN in supernatants 3 months post-BCG vaccination by
ELISA [6] were selected for additional cytokine analysis. Of these
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Table 1
Median response in 21 cytokines and chemokines.
Cytokine Unvac median (pg/ml) Vac median (pg/ml) Median fold difference P value
Pro-inﬂammatory cytokine IFN 1.6 1705 1066 P<0.0001
TNF 18 226 13 P<0.0001
IL-2 1.6 17 11 P<0.0001
IL-1 4 145 36 P<0.0001
IL-6 227 855 4 P=0.0003
TH17 cytokine IL-17 1.6 17 11 P<0.0001
TH2 cytokine IL-4 1.6 10 6 P=0.013
IL-5 1.6 7 4 P=0.0005
IL-13 1.6 104 65 P<0.0001
Regulatory cytokine IL-10 8 96 12 P<0.0001
Chemokine IL-8 1621 20,562 13 P=0.0073
IP-10 99 2122 21 P<0.0001
MIP-1 1.6 454 284 P<0.0001
Growth factor GCS-F 1.6 21 13 P=0.012
GM-CSF 14 420 30 P<0.0001
No evidence of a difference between
vaccinated and unvaccinated infants
IL12p70 1.6 1.6 1 P=0.49
IL-15 1.6 1.6 1 na
Eotaxin 1.6 7 4 P=0.13
MCP-1 6932 1560 0 P=0.54
IL-1 1.6 1.6 1 P=0.08
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upernatants from diluted blood samples stimulated withM.tb PPD for 6 days were
nfants 3 months post-BCG vaccination. Median fold differences and P values for sig
nfants, 19 had been BCG vaccinated between 5 and 10 weeks
f age (mean 7 weeks), and 9 had not received BCG. Approval
or the study was given by the Redbridge and Waltham For-
st Health Authority Local Research Ethics Committee, and the
thics Committee of the London School of Hygiene & Tropical
edicine.
.2. Whole blood assay, IFN ELISA
Whole blood assays and ELISAs for IFN were carried out
s previously described [10,11]. Heparinised whole blood was
iluted 1 in 10 and cultured on the day of collection with
he M.tb PPD (Statens Serum Institut, Copenhagen (SSI), RT49,
ot 204) at a concentration of 5g/ml or medium alone
unstimulated) as the negative control. PHA-P was used as a
ositive control; IFN from PHA-P cultures was measured by
LISA [6] but were not included in the Multiplex assay. Cul-
ures were incubated at 37 ◦C with 5% CO2; supernatants were
arvested on day 6 and stored at −70 ◦C until assayed for
FN in single 100l samples by quantitative ELISA or for 21
able 2
pearman’s correlation coefﬁcients (r) of cytokine responses.
IFN TNF IL-2 IL-1 IL-6 IL-17 IL-4 IL
IFN 1.0
TNF 0.8 1.0
IL-2 0.6 0.6 1.0
IL-1 0.6 0.7 0.4 1.0
IL-6 0.8 0.7 0.6 0.7 1.0
IL-17 −0.1 −0.1 −0.5 0.1 −0.1 1.0
IL-4 0.3 0.2 0.2 0.0 0.2 0.3 1.0
IL-5 0.6 0.7 0.2 0.5 0.4 0.4 0.4 1.
IL-13 0.7 0.7 0.5 0.3 0.5 0.0 0.2 0.
IL-10 −0.2 −0.3 −0.4 −0.2 −0.3 0.7 0.5 0.
IL-8 0.8 0.7 0.4 0.4 0.7 0.0 0.1 0.
IP-10 0.4 0.2 0.3 0.0 0.3 0.3 0.6 0.
MIP-1 0.5 0.7 0.4 0.8 0.7 −0.2 −0.2 0.
G-CSF 0.4 0.6 0.4 0.9 0.5 0.0 −0.2 0.
GM-CSF 0.8 0.8 0.6 0.7 0.8 −0.1 0.2 0.
pearman’s correlation coefﬁcients (r) are presented from supernatants from diluted bl
onths post-vaccination. Shaded boxes show r values 0.6 and above.1.6 1 P=0.12
for 21 cytokines and chemokines from unvaccinated (Unvac) and vaccinated (Vac)
nce testing by the Mann–Whitney test are also presented (na is not applicable).
cytokines and chemokines in single 25l samples by Multiplex
assay.
2.3. 21-plex Multiplex
The following 21 cytokines and chemokines were measured
simultaneously in supernatants using a human cytokine Lincoplex
premixed kit according to the manufacturer’s instructions (cat
#HCYTO-60K-PMX, Linco Research Inc., St. Charles Missouri, USA):
IL-1, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p70, IL-13, IL-
15, IL-17, IL-1, IFN, G-CSF, GM-CSF, TNF, Eotaxin, MCP-1,
MIP-1 and IP-10. Unstimulated, M.tb PPD stimulated and 1 in
10 diluted M.tb PPD stimulated samples were read on the Bio-
rad Luminex reader using Bioplex manager 4.1 software. For
each cytokine the standard curve ran from 3.2 to 10,000pg/ml.
The reproducibility of the assay for individual cytokines and
chemokines was determined using the quality controls provided
with the kit. For all 21 cytokines and chemokines, the coefﬁ-
cients of variation for the low control were 7.5% or less. There
-5 IL-13 IL-10 IL-8 IP-10 MIP-1 G-CSF GM-CSF
0
7 1.0
3 −0.2 1.0
5 0.7 −0.3 1.0
4 0.3 0.4 0.2 1.0
4 0.4 −0.5 0.6 −0.2 1.0
4 0.2 −0.3 0.3 −0.1 0.8 1.0
4 0.6 −0.4 0.7 0.3 0.8 0.6 1.0
ood samples stimulated with M.tb PPD for 6 days from BCG vaccinated infants 3
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sig. 1. Cytokine responses in BCG vaccinated and unvaccinated infants. Cytokines i
or 6 days were measured using a Multiplex assay in infants who had been BCG v
ytokines IL-1, IL-2, IL-6, TNF and IFN, TH17 cytokine IL-17, TH2 cytokines IL-4
as greater variation in the high control: 15 cytokines had coef-
cients of variation below 25%, but for 6 cytokines the variation
as greater (26–44%). However, as only 8/588 data values pre-
ented were within the high range of these cytokines we believe
his variation will have had only a small effect on the data pre-
ented.rnatants from diluted whole blood cultures which were stimulated with M.tb PPD
ated 3 months previously and in unvaccinated control infants. Pro-inﬂammatory
IL-13, chemokines IL-8, IP-10, MIP-1 and growth factors G-CSF, GM-CSF.
2.4. Statistical analysisData were analysed using Stata 10. Unstimulated cytokine
responses were subtracted from antigen stimulated results. For
Multiplex, data values below 3.2pg/ml were assigned as 1.6pg/ml
and for values over the detection limit the 1/10 diluted sample
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ith M.tb PPD for 6 days in infants who had been BCG vaccinated 3 months previou
esult was multiplied by 10 and used. For MCP-1, IL-8 and IP-10,
ome values were above the detection limit and were assigned
0,000pg/ml for MCP-1 and IP-10, and 100,000pg/ml for IL-8,
ssessed by looking at the highest values that were measured for
hose chemokines. One TNF measurement was excluded as the
nstimulated sample had higher levels of TNF than the M.tb PPD
timulated sample.
Non-parametric Mann–Whitney tests were used to compare
ytokine responses between vaccinated and unvaccinated infants.
edian fold differences were calculated, and correlations between
FN measured by ELISA or Multiplex, and between different
ytokines measured by Multiplex, were assessed by calculating a
pearman’s rank correlation.
Principal components analysis was conducted on the logytokine data from vaccinated infants (n=18), restricted to ﬁfteen
ytokines (IL-1, IL-2, IL-6, TNF, IFN, IL-17, IL-4, IL-5, IL-13, IL-
0, IL-8, IP-10, MIP-1, G-CSF and GM-CSF) for which there was
vidence of a difference between unvaccinated and vaccinated
nfants (P<0.01). (One infantwas excluded as their TNF valuewasex assay in supernatants from diluted whole blood cultures which were stimulated
not included in the analysis.) The principal components analysis
was done on “standardised” log cytokine measurements (with the
mean response subtracted from the observed value, and this value
divided by the standard deviation), by using the correlation matrix
for the identiﬁcation of principal components. Principal compo-
nents analysis was then conducted restricted to particular groups
of cytokines; pro-inﬂammatory cytokines (IL-1, IL-2, IL-6, TNF
and IFN), and TH2 cytokines (IL-4, IL-5, IL-13).
3. Results
Of the vaccinated infants, 4/19made relatively low (<500pg/ml)
IFN responses, 8/19 made high (>500pg/ml, <2000pg/ml) IFN
responses, and 7/19 made very high IFN responses (>2000pg/ml)
in cultures stimulated with M.tb PPD, as measured by ELISA. IFN
to M.tb PPD measured by Multiplex correlated very strongly with
the IFNmeasured in the ELISA (r=0.9). For 15 of the 21 cytokines
tested there was strong evidence that responses in the vaccinated
infantswerehigher than in theunvaccinated infants (Table1, Fig. 1).
cine 28 (2010) 1635–1641 1639
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Table 3
Principal components analysis.
Component Eigenvalue Difference Proportion Cumulative
Component 1 7.28 4.3 0.49 0.49
Component 2 2.98 1.64 0.2 0.68
Component 3 1.33 0.33 0.09 0.77
Component 4 1.01 0.18 0.07 0.84
Component 5 0.83 0.35 0.06 0.9
Component 6 0.48 0.15 0.03 0.93
Component 7 0.33 0.09 0.02 0.95
Component 8 0.24 0.08 0.02 0.97
Component 9 0.16 0.05 0.01 0.98
Component 10 0.11 0.02 0.01 0.98
Component 11 0.08 0.02 0.01 0.99
Component 12 0.07 0.03 0 0.99
Component 13 0.04 0.01 0 1
Component 14 0.03 0.03 0 1
Component 15 0.01 0 1
Variable Component 1 Component 2
Log IFN 0.33 0.11
Log IL-2 0.26 −0.1
Log IL-4 0.08 0.45
Log IL-5 0.25 0.3
Log IL-6 0.3 −0.09
Log IL-8 0.31 −0.01
Log IL-10 −0.11 0.5
Log IL-13 0.25 0.13
Log IL-17 0.01 0.39
Log IL-1 0.31 −0.15
Log G-CSF 0.26 −0.16
Log GM-CSF 0.34 0.03
Log TNF 0.34 0.06
Log MIP-1 0.3 −0.17
Log IP-10 0.1 0.43
unvaccinated infants were clearly separated into two groups and
also the variation among individuals who were vaccinated was
muchmore simply summarised (Fig. 3). Principal component anal-
ysis of the ﬁve pro-inﬂammatory cytokines measured showed thatM.K. Lalor et al. / Vac
herewasnoorweak associations between cytokine responses and
ymphocyte numbers (data not shown).
For the purposes of presenting the results from so many
ytokines, cytokines have been grouped into pro-inﬂammatory
ytokines (IFN, IL-2, TNF, IL-1 and IL-6), TH2 cytokines (IL-
, IL-5, IL-13), regulatory cytokine (IL-10), TH17 cytokine (IL-17),
hemokines (IL-8, IP-10, MIP-1) and growth factors (G-CSF and
M-CSF), althoughwe recognise that these groupingsmay be over-
implistic.
Five pro-inﬂammatory cytokines were strongly induced by
CG vaccination: IFN (P<0.0001) which had a median value of
705pg/ml in the vaccinated group compared with 1.6pg/ml in
he unvaccinated group, TNF (226pg/ml vaccinated vs. 18pg/ml
nvaccinated, P<0.0001), IL-2 (17pg/ml vaccinated vs. 1.6 pg/ml
nvaccinated, P<0.0001), IL-1 (145pg/ml vaccinated vs. 4 pg/ml
nvaccinated, P<0.0001) and IL-6 (855pg/ml vaccinated vs.
27pg/ml unvaccinated, P=0.0003). There was also strong evi-
ence that the pro-inﬂammatory cytokine IL-17 was induced by
CG vaccination (17pg/ml vaccinated vs. 1.6 pg/ml unvaccinated,
< 0.0001).
There was strong evidence that three TH2 cytokines were
lso induced by BCG vaccination: IL-4 (10pg/ml vaccinated vs.
.6 pg/ml unvaccinated, P=0.013), IL-5 (7pg/ml vaccinated vs.
.6 pg/ml unvaccinated, P=0.0005) and IL-13 (104pg/ml vacci-
ated vs. 1.6 pg/ml unvaccinated, P<0.0001).
There was also strong evidence that the regulatory cytokine
L-10 was induced by BCG vaccination (96pg/ml vaccinated
s. 8 pg/ml unvaccinated, P<0.0001). Three chemokines: IL-8
20,562pg/ml vaccinated vs. 1621pg/ml unvaccinated, P=0.0073),
P-10 (2122pg/mlvaccinatedvs. 99pg/mlunvaccinated,P<0.0001)
nd MIP-1 (454pg/ml vaccinated vs. 1.6 pg/ml unvaccinated,
< 0.0001) were induced by BCG vaccination. The growth factors
-CSF (21pg/ml vaccinated vs. 1.6 pg/ml unvaccinated, P=0.012)
nd GM-CSF (420pg/ml vaccinated vs. 14pg/ml unvaccinated,
< 0.0001) were also induced. There were six cytokines (IL-1, IL-
, IL-12p70, IL-15, Eotaxin and MCP-1) for which there was no
tatistical evidence of a median difference between responses in
accinated and unvaccinated infants, and (with the exception of
otaxin) the median responses were either very similar in the two
roups or higher in the unvaccinated group (Table 1).
Correlations between cytokines where there was evidence of
difference between vaccinated and unvaccinated infants were
xamined by Spearman’s rank correlation, among the vaccinated
roup (Table 2). Eight out of 14 cytokines correlated moderately
trongly or strongly with IFN, and ten correlated with TNF. IFN
nd TNF correlated strongly with each other (r=0.8). IFN and
NF correlatedwithpro-inﬂammatory cytokines suchas IL-2with
FN (r=0.6) and IL-2withTNF (r=0.6) and IL-6with IFN (r=0.8),
ut alsowithTH2cytokines suchas IL-13with IFN (r=0.7) and IL-5
ith IFN (r=0.6). IFN and TNF also correlatedwith chemokines
nd growth factors, for example IFN with IL-8 (r=0.8) and IFN
ith GM-CSF (r=0.8) (Fig. 2).
Cytokines for which there was no statistical evidence of corre-
ation with IFN or TNF included IL-17 and IL-10. IL-17 and IL-10
ere correlated with each other (r=0.7, Fig. 2), however the corre-
ations between IL-10 or IL-17 and other cytokines, were weak and
egative (Fig. 2). Adding the “standardised” TH1 responses together
IFN, TNF, IL-1, IL-6 and IL-2), and calculating the correlation
ith the “standardised” IL-10 response, gave a correlation coefﬁ-
ient of−0.4, whichwas considerably larger inmagnitude than any
f the individual correlations between a TH1 cytokine and IL-10.
From the principal components analysis, 90% of the total vari-
tion in the responses of the 15 cytokines could be summarised
y 5 components. The ﬁrst component alone accounted for 49% of
he total variation and corresponded approximately to the aver-
ge of the “standardised” log responses to IFN, IL-1, IL-2, IL-6,Principal components analysis of 15 cytokines from supernatants stimulated with
M.tb PPD from infants 3 months post-BCG vaccination. Shaded boxes show impor-
tant cytokines in the component.
TNF, IL-5, IL-13, IL-8, MIP-1, G-CSF and GM-CSF. The second
component is independent of the ﬁrst one, and describes a further
20% of the remaining variation and corresponded approximately
to the average of the “standardised” log response to IL-4, IL-5, IL-
10, IL-17 and IP-10 (Table 3). Using the two components to explain
the variation within the 15 cytokines included, the vaccinated andFig. 3. Score values for components 1 and 2. Score values for vaccinated (triangles)
and unvaccinated infants (diamonds) for components 1 and 2 from the principal
components analysis.
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3%of the total variation couldbe explainedby theﬁrst component,
nd this correspondedapproximately to theaverage “standardised”
esponse to the 5 cytokines.
. Discussion
Wehavepreviously shown thatBCGvaccinated infants in theUK
ade IFN toM.tb PPD in6-daydilutedwhole blood cultures,while
nvaccinated infants did not make a detectable IFN response [6].
The Multiplex assay enabled us to test for multiple cytokines
n the same supernatant sample, and 6 out of the 21 cytokine
esponses tested showed no evidence of a difference in production
etween the vaccinated and unvaccinated infants. These included
L-12p70, IL-1, IL-15, Eotaxin, and IL-7whichwere present in very
ow to undetectable concentrations in supernatants of stimulated
ultures for both vaccinated and unvaccinated infants. This may
e due to the cytokines not being produced in M.tb PPD stimu-
ated cultures during the 6 days of culture at this time point since
accination, i.e. at 3 months post-BCG vaccination, to their being
roduced but not remaining in the supernatant for the 6 days
f culture, or to their being produced at levels undetectable by
he Multiplex assay despite the increased sensitivity of this assay
ompared to ELISA. Responses to MCP-1 were seen in both vacci-
ated and unvaccinated infants andmay reﬂect non-mycobacterial
peciﬁc responses. We showed that BCG vaccination induced pro-
nﬂammatory cytokines such as IFN and TNF which are known
o activate M.tb infected macrophages, and IL-2 which promotes
timulation of TH1 cells and CD8 T cells. We also showed that
CG vaccination induced IL-1 and IL-6 following BCG vaccina-
ion. There is little known about the role of IL-1 in immunity
o TB; a TB case–control study in the Gambia suggested it may
lay a role in TB susceptibility [12]. In TB patients from Pak-
stan IL-6 was shown to be increased in Culture Filtrate Protein
timulated supernatants compared to controls [13], and in South
frican TB patients IL-6 was increased in plasma compared to
ealthy endemic controls [14]. IL-6 has been regarded as a pro-
nﬂammatory cytokine, however it has been shown to display
nti-inﬂammatory properties which can inhibit TNF production
n CD8 T cell supernatants stimulated withmycobacterial fractions
15].
We were interested in whether those infants with greater IFN
esponses alsomade greater pro-inﬂammatory cytokine responses
nd smaller TH2 cytokine responses.We found that IFN responses
orrelated positively with production of 9 cytokines including the
ther pro-inﬂammatory cytokines measured, but also with that of
he TH2 cytokines IL-5 and IL-13 and with the chemokine IL-8 and
rowth factor GM-CSF. The greatest fold difference between vacci-
ated andunvaccinated cytokine responseswas seen for IFN. This,
longwith the strong evidence for correlationswithmanydifferent
ypes of cytokine, highlights the importance of IFN in immunity
or TB induced by BCG vaccination.
Interestingly, IL-17 (a pro-inﬂammatory cytokine produced by
he recently described TH17 T cell subset [16]) was induced by
CG vaccination, but there was no evidence that it correlated with
he IFN response. This may imply that, if there is TH17 mediated
mmunity inducedbyBCGvaccination, it is independent of the IFN
ediated immunity and may be produced by different cells than
hose which produce IFN. IL-17 has been shown to play a role in
utoimmune disease [17–19], but has also recently been thought
o play a role in M.tb infection [20], as it was shown to upregu-
ate chemokines which led to increased recruitment of TH1 cells
21], and is also thought to recruit neutrophils to facilitate gran-
loma formation [22]. There is evidence that TB patients produce
ess IL-17 following overnight culture with ESAT6/CFP10 than con-
acts [23]. IL-17 has also been shown to regulate IFN production
n cell cultures stimulated withM.tb in TB patients [24], and the IL-8 (2010) 1635–1641
17 producing CD4+ T cells had characteristics of long lived central
memory cells but many do not produce IFN [25].
The role of TH2 cytokines such as IL-4, IL-5 and IL-13 in the
immune response toMycobacterium tuberculosis has been debated,
and it has been suggested that TH2 responses reﬂect inappropri-
ate or suboptimal immune responses tomycobacteria [26]. Several
human studies have shown that IL-4 production is increased in
tuberculosis patients compared with controls [27–30]. Studies in
mice with disrupted IL-4 genes showed there was no evidence
of a change in resistance to M.tb infection [31], although with
respect to IL-4 somemousemodels do not provide a goodmodel of
human immunopathology [32]. It is possible that the TH2 cytokine
responses and the IL-10 responses do not simply reﬂect a regu-
lation of the IFN responses, but may also reﬂect that there is a
polyclonal response of mixed T cell populations, and some of the
IL-10measuredmay be produced by fully differentiated TH1 T cells
[33,34].
In Malawian infants, a smaller increase in TH1 cytokines
has been seen following BCG vaccination than in the UK [6],
and one hypothesis for this is that there may be suppres-
sion/immunoregulation by TH2 cytokines and/or by T regulatory
cells and IL-10. We found a signiﬁcant increase in TH2 cytokines
IL-4, IL-5 and IL-13, and also in the regulatory cytokine IL-10 fol-
lowing BCG vaccination in UK infants who we presume made an
immune response to BCG that was protective against the dissem-
inated childhood forms of TB. The high levels of TH2 cytokines
seen in the UK vaccinated infants may have been produced in
response to the high levels of IFN produced, in order to regu-
late the IFN response. IL-5 and IL-13 both correlated positively
with the IFN response in vaccinated infants, but the correlation
between the IL-10 and IFN response was weak and negative.
There was stronger evidence of a negative association between
pro-inﬂammatory responses and IL-10 when all pro-inﬂammatory
responses were added together, possibly suggesting that IL-10 reg-
ulates the entire pro-inﬂammatory cytokine proﬁle.
Chemokines have been shown to be important in immunity to
tuberculosis [35], particularly in cellular trafﬁcking for granuloma
formation [36]. We found that the chemokines IL-8 (CXCL8), IP-10
(CXCL10) and MIP-1 (CCL3) were all induced by BCG vaccination.
The growth factors G-CSF and GM-CSF were also increased in
BCG vaccinated infants; GM-CSF has been shown to have many
roles in immunity to TB such as inducing the generation and prolif-
eration of cells such as macrophages, DCs and neutrophils, but also
by acting to recruit leukocytes and to enhance APC function and
may be necessary for optimum T cell immunity [37,38].
Principal components analysiswasperformed inorder to reduce
the dimensionality of the data, to attempt to summarise the overall
patternof responseamong the15cytokines.Wesummarised68%of
the total variation in thedatabyusing just 2 components. These two
components suggest that all 15 cytokines and chemokines mea-
sured are important, rather than just a particular subset, and that all
15 cytokines and chemokines are useful in describing the variation
in immune response among individuals.
This study identiﬁed several cytokines and chemokines (IFN,
TNF, IL-2, IL-6, IL-1, IL-4, IL-5, IL-13, IL-10, IL-8, IP-10, MIP-1,
G-CSF, GM-CSF) which when measured together could be used
as biomarkers for protection in future studies and clinical trials.
Further studies examining cytokine responses in individuals from
populations inwhich BCGdoes not offer good protection have been
planned, and studies to establish which cells are producing these
cytokines, and the kinetics involved, are warranted.Polyfunctional CD4+ T cells have recently been shown to be
induced following BCG and recombinantMVA85A vaccination [39].
We suggest that future vaccine trials might measure cytokines
released into supernatants by Multiplex as a ﬁrst step, in order
to identify key cytokines for more detailed study, followed by
cine 2
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Immunisation with BCG and recombinant MVA85A induces long-lasting, poly-M.K. Lalor et al. / Vac
easurement of these key cytokines and chemokines using multi-
olour FACS to determine if polyfunctional cells have been induced.
ith the current focus on polyfunctional cells [25,39,40], this study
eminds us of the importance of measuring additional cytokines
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o focus on those we know are important.
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